Thomas Kaley
Impact in
Papers in
- Co-authors
- Lisa M. DeAngelis (21 shared papers)Patrick Y. Wen (17 shared papers)Michael McDermott (3 shared papers)David Schiff (7 shared papers)Igor T. Gavrilovic (21 shared papers)Igor J. Barani (3 shared papers)Antonio Omuro (18 shared papers)Damien C. Weber (2 shared papers)
- Journals
- Journal of Clinical Oncology (23 papers)Neuro-Oncology (16 papers)Journal of Neuro-Oncology (7 papers)Neurology (6 papers)Blood (5 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Thomas Kaley
77 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Genetics 1.2k
- Neurology 1.1k
- Epidemiology 1.1k
- Pathology and Forensic Medicine 372
- Endocrinology, Diabetes and Metabolism 314
Countries citing papers authored by Thomas Kaley
This map shows the geographic impact of Thomas Kaley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kaley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kaley more than expected).
Fields of papers citing papers by Thomas Kaley
This network shows the impact of papers produced by Thomas Kaley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kaley. The network helps show where Thomas Kaley may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Kaley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review Hit paper breakdown → | 2014 | 465 |
| 2 | 2015 | 247 | |
| 3 | 2014 | 194 | |
| 4 | 2014 | 175 | |
| 5 | 2009 | 143 | |
| 6 | 2012 | 136 | |
| 7 | 2018 | 117 | |
| 8 | 2015 | 98 | |
| 9 | 2012 | 74 | |
| 10 | 2018 | 47 | |
| 11 | 2019 | 43 | |
| 12 | 2019 | 43 | |
| 13 | 2015 | 41 | |
| 14 | 2015 | 41 | |
| 15 | 2016 | 41 | |
| 16 | 2017 | 41 | |
| 17 | 2020 | 41 | |
| 18 | 2012 | 39 | |
| 19 | 2018 | 38 | |
| 20 | 2017 | 37 |
About Thomas Kaley
Thomas Kaley is a scholar working on Genetics, Neurology, Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 83 papers that have together received 2.6k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (48 papers), Brain Metastases and Treatment (16 papers), Meningioma and schwannoma management (14 papers), CNS Lymphoma Diagnosis and Treatment (12 papers), Lymphoma Diagnosis and Treatment (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Treatment and Pharmacology (8 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Genetics (1.2k citations), Neurology (1.1k citations), Epidemiology (1.1k citations), Pathology and Forensic Medicine (372 citations) and Endocrinology, Diabetes and Metabolism (314 citations). Thomas Kaley has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Lisa M. DeAngelis, Patrick Y. Wen, Michael McDermott, David Schiff, Igor T. Gavrilovic, Igor J. Barani, Antonio Omuro, Damien C. Weber, Leland Rogers and Craig Nolan. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Neurology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.